RETREG1 and neoplasm: In contrast, FAM134B loss may promote colorectal cancer tumorigenicity (81) pointing to a tumor suppressor role for FAM134B-mediated ER-phagy, suggesting that targeting this pathway in colorectal cancer is not a good strategy.